137 related articles for article (PubMed ID: 38157300)
1. Heterogeneity in glycaemic control in children and adolescents with type 1 diabetes: A latent class trajectory analysis of Danish nationwide data.
Wibaek R; Ibfelt EH; Andersen GS; Hulman A; Dabelea D; Jørgensen ME; Svensson J; Vistisen D; Rønn PF
Diabet Med; 2024 Mar; 41(3):e15275. PubMed ID: 38157300
[TBL] [Abstract][Full Text] [Related]
2. Trajectory and predictors of HbA1c in children and adolescents with type 1 diabetes-A Danish nationwide cohort study.
Ibfelt EH; Wibaek R; Vistisen D; Andersen GS; Jørgensen ME; Hulman A; Dabelea D; Birkebaek NH; Svensson J; Rønn PF
Pediatr Diabetes; 2022 Sep; 23(6):721-728. PubMed ID: 35366046
[TBL] [Abstract][Full Text] [Related]
3. Association between glycaemic outcome and BMI in Danish children with type 1 diabetes in 2000-2018: a nationwide population-based study.
Ibfelt EH; Vistisen D; Falberg Rønn P; Pørksen S; Madsen M; Kremke B; Svensson J
Diabet Med; 2021 Mar; 38(3):e14401. PubMed ID: 32918312
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous long-term trajectories of glycaemic control in type 1 diabetes.
Miller RG; Orchard TJ; Onengut-Gumuscu S; Chen WM; Rich SS; Costacou T
Diabet Med; 2021 Aug; 38(8):e14545. PubMed ID: 33605492
[TBL] [Abstract][Full Text] [Related]
5. HbA1c tracking and bio-psychosocial determinants of glycaemic control in children and adolescents with type 1 diabetes: retrospective cohort study and multilevel analysis.
Lawes T; Franklin V; Farmer G
Pediatr Diabetes; 2014 Aug; 15(5):372-83. PubMed ID: 24279611
[TBL] [Abstract][Full Text] [Related]
6. Distinct trajectories of HbA
Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
[TBL] [Abstract][Full Text] [Related]
7. Episodes of severe hypoglycemia is associated with a progressive increase in hemoglobin A1c in children and adolescents with type 1 diabetes.
Pilgaard KA; Breinegaard N; Johannesen J; Pörksen S; Fredheim S; Madsen M; Kristensen K; Svensson J; Birkebaek NH
Pediatr Diabetes; 2020 Aug; 21(5):808-813. PubMed ID: 32304129
[TBL] [Abstract][Full Text] [Related]
8. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
Olsen B; Johannesen J; Fredheim S; Svensson J;
Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
[TBL] [Abstract][Full Text] [Related]
9. Five heterogeneous HbA1c trajectories from childhood to adulthood in youth with type 1 diabetes from three different continents: A group-based modeling approach.
Clements MA; Schwandt A; Donaghue KC; Miller K; Lück U; Couper JJ; Foster N; Schröder C; Phelan H; Maahs D; Prinz N; Craig ME;
Pediatr Diabetes; 2019 Nov; 20(7):920-931. PubMed ID: 31418521
[TBL] [Abstract][Full Text] [Related]
10. Continuous glucose monitoring systems for type 1 diabetes mellitus.
Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
[TBL] [Abstract][Full Text] [Related]
11. Data-driven long-term glycaemic control trajectories and their associated health and economic outcomes in Finnish patients with incident type 2 diabetes.
Lavikainen P; Aarnio E; Linna M; Jalkanen K; Tirkkonen H; Rautiainen P; Laatikainen T; Martikainen J
PLoS One; 2022; 17(6):e0269245. PubMed ID: 35648780
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Trajectories of Metabolic Control From Childhood to Young Adulthood in Type 1 Diabetes From a Large German/Austrian Registry: A Group-Based Modeling Approach.
Schwandt A; Hermann JM; Rosenbauer J; Boettcher C; Dunstheimer D; Grulich-Henn J; Kuss O; Rami-Merhar B; Vogel C; Holl RW;
Diabetes Care; 2017 Mar; 40(3):309-316. PubMed ID: 28007778
[TBL] [Abstract][Full Text] [Related]
13. Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls.
Nathanson D; Svensson AM; Miftaraj M; Franzén S; Bolinder J; Eeg-Olofsson K
Diabetologia; 2021 Jul; 64(7):1595-1603. PubMed ID: 33774713
[TBL] [Abstract][Full Text] [Related]
14. Treatment intensification without improved HbA1c levels in children and adolescents with Type 1 diabetes mellitus.
Sildorf SM; Hertel NT; Thomsen J; Fredheim S; Hastrup H; Pipper C; Hertz B; Svensson J;
Diabet Med; 2016 Apr; 33(4):515-22. PubMed ID: 26333180
[TBL] [Abstract][Full Text] [Related]
15. Identifying HbA1c trajectories and modifiable risk factors of trajectories in 5- to 9-year-olds with recent-onset type 1 diabetes from the United States.
Patton SR; Feldman K; Majidi S; Noser A; Clements MA
Diabet Med; 2021 Sep; 38(9):e14637. PubMed ID: 34240466
[TBL] [Abstract][Full Text] [Related]
16. Association of Glycemic Control Trajectory with Short-Term Mortality in Diabetes Patients with High Cardiovascular Risk: a Joint Latent Class Modeling Study.
Raghavan S; Liu WG; Berkowitz SA; Barón AE; Plomondon ME; Maddox TM; Reusch JEB; Ho PM; Caplan L
J Gen Intern Med; 2020 Aug; 35(8):2266-2273. PubMed ID: 32333313
[TBL] [Abstract][Full Text] [Related]
17. Glycaemic outcomes in Australasian children and adults with type 1 diabetes: failure to meet targets across the age spectrum.
Holmes-Walker DJ; Abraham MB; Chee M; Jones TW;
Intern Med J; 2023 Jan; 53(1):61-67. PubMed ID: 34142758
[TBL] [Abstract][Full Text] [Related]
18. Effect of 6 months' flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a 'flash' randomised controlled trial protocol.
Boucher SE; Gray AR; de Bock M; Wiltshire EJ; Galland BC; Tomlinson PA; Rayns J; MacKenzie KE; Wheeler BJ
BMC Endocr Disord; 2019 May; 19(1):50. PubMed ID: 31109342
[TBL] [Abstract][Full Text] [Related]
19. Identification and prediction of group-based glycemic control trajectories during the transition to adolescence.
Rohan JM; Rausch JR; Pendley JS; Delamater AM; Dolan L; Reeves G; Drotar D
Health Psychol; 2014 Oct; 33(10):1143-52. PubMed ID: 24274797
[TBL] [Abstract][Full Text] [Related]
20. HbA1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER study.
Bongaerts B; Kuss O; Bonnet F; Chen H; Cooper A; Fenici P; Gomes MB; Hammar N; Ji L; Khunti K; Medina J; Nicolucci A; Shestakova MV; Watada H; Rathmann W
Diabetes Obes Metab; 2023 Jul; 25(7):1890-1899. PubMed ID: 36906837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
